Protea Biosciences Group Inc (NASDAQ:PRGB) Director Stanley Hostler purchased 293,333 shares of the stock in a transaction dated Thursday, November 3rd. The stock was acquired at an average cost of $0.08 per share, for a total transaction of $23,466.64. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Protea Biosciences Group Inc (NASDAQ:PRGB) opened at 0.12 on Thursday. The company’s 50-day moving average is $0.12 and its 200 day moving average is $0.15. Protea Biosciences Group Inc has a 52 week low of $0.08 and a 52 week high of $0.40. The stock’s market cap is $16.05 million.

Protea Biosciences Group Company Profile

Protea Biosciences Group, Inc is a molecular information company. The Company is engaged in developing and commercializing life science technologies, products and services to identify the molecules that are produced by living cells and all life forms. It also offers a platform technology, Laser Ablation Electrospray Ionization (LAESI), which enables the direct analysis, mapping and display of molecular information in living cells and tissue samples.

5 Day Chart for NASDAQ:PRGB

Receive News & Stock Ratings for Protea Biosciences Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Protea Biosciences Group Inc and related stocks with our FREE daily email newsletter.